Search

everythinglearnresearchcommunity

for

Search:↓

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Understanding EGFR roles could lead to new hair loss treatments.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Combining bromelain with finasteride improves hair regrowth and reduces inflammation in alopecia.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Altering the keratin 17 gene in mice hair follicles caused temporary hair issues, but changes were minimal and short-lived.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

A new compound shows promise as a topical treatment for hair loss.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Topical rapamycin may effectively treat fibrous papules on the face.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Finasteride use may increase the risk of male breast cancer.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.